WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Stock Ownership - Who owns Aprea Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Aprea Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Oren GiladPresident CEO2024-03-132,000$7.29
$14.58kBuy
John P. HamillSrVPCFOPrin Fin Acct Ofcr2024-03-131,010$7.29
$7.36kBuy
John B. Henneman IiiDirector2024-03-136,860$7.29
$50.01kBuy
Bernd R. SeizingerDirector2024-03-136,860$7.29
$50.01kBuy
Bernd R. SeizingerDirector2023-06-076,029$3.68
$22.19kBuy
Bernd R. SeizingerDirector2023-06-064,068$3.63
$14.76kBuy

1 of 1

APRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APRE insiders and whales buy or sell their stock.

APRE Shareholders

What type of owners hold Aprea Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Tryant LLC515.63%28,000,000$144.76MInsider
Thomas Banks246.60%13,391,146$69.23MInsider
Frank J. Hall88.06%4,781,889$24.72MInsider
David West Wilson53.86%2,924,726$15.12MInsider
Heidi A. Patterson49.50%2,688,221$13.90MInsider
Kdev Investments Ab36.69%1,992,586$10.30MInsider
Michael Reynolds36.46%1,980,040$10.24MInsider
Redmile Group LLC32.57%1,768,718$9.14MInsider
Aigh Capital Management LLC6.43%349,300$1.81MInstitution
Oren Gilad6.14%333,295$1.72MInsider

1 of 3

APRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APRE1.54%98.46%Net BuyingNet Buying
DARE6.57%25.43%
SPRB63.59%36.41%Net SellingNet Selling
NTRB2.49%72.38%
APM0.85%40.28%
View Top Biotech Stocks

Aprea Therapeutics Stock Ownership FAQ

Who owns Aprea Therapeutics?

Aprea Therapeutics (NASDAQ: APRE) is owned by 17.05% institutional shareholders, 1,092.42% Aprea Therapeutics insiders, and 0.00% retail investors. Tryant LLC is the largest individual Aprea Therapeutics shareholder, owning 28.00M shares representing 515.63% of the company. Tryant LLC's Aprea Therapeutics shares are currently valued at $149.80M.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.